Furthermore, the blockade or modulation of inhibitory receptors such as PD1, TIGIT, TIM3, KIRs (Killer-cell Immunoglobulin-like Receptors) on NK cells, which interact with MHC class I molecules on tumor cells (100, 101). Here, PDCD1 is linked to neoplasm.